Global Innovative Platforms Inc. · OTC:GIPL

Global Innovative Platforms — Investor Presentation (September 2025)

15 slides from Global Innovative Platforms's investor presentation, Sep 26, 2025

  1. Slide 1: Vet Breath Analytics: A Diagnostic Revolution

    Vet Breath Analytics A Division Of Global Innovative Platforms Inc. A Diagnostic Revolution

  2. Slide 2: Forward Looking Statements

    Forward Looking Statements This presentation includes "forward-looking statements." To the extent that the information presented in this presentation discusses financial projections, information, or expectations about our business plans, results of operations, products or markets, or otherwise makes

  3. Slide 3: Breathomics

    Breathomics The study of volatile organic compo exhaled breath. Metabolism prod change with disease states, allow offer a non-invasive diagnostic op}

  4. Slide 4: How It Works

    HOW IT WORKS VOCs are exhaled in specific combinations and proportions, producing a distinct Sos > “breath marker” Disease states produce specific combinations of volatile organic eos > compounds (VOCs) ' Gas chromatography unit detects > @eeeee Disease-specific VOC breath markers iw

  5. Slide 5: Human Medical Uses & Research

    HUMAN MEDICAL USES & RESEARCH Multiple trials show breath VOC profiles can detect lung cancer. This is a dynamic area of research.” Diabetes Breath Acetone for Diabetes (Ketoacidosis Monitoring) - Several handheld breath ketone meters are clinically marketed and approved for patient monitoring.° oo

  6. Slide 6: Heartworm Disease AHS Recommendations

    HEARTWORM DISEASE AHS RECOMMENDATIONS ‘; The American Heartworm Society recommends that An Ideal Animal Health all dogs 6 months and older be tested annually for heartworm di Current Jard is a blood test. Starting Point INFECTION DETECTION > > > DD Lou With blood-based diagnostics, there is a six mo

  7. Slide 7: Traditional Diagnostics

    TRADITIONAL DIAGNOSTICS Invasive Specialized skills Blood samples Ongoing consumables Risk of human needle sticks

  8. Slide 8: Breathomics

    oW . BREATHOMICS Non-invasive No specialized training No reagents or other consumables Results in minutes

  9. Slide 9: Early Detection Goal

    EARLY DETECTION GOAL Detect heartworm infection at earlier stages Prevention instead of costly treatment First to market solution EARLY DETECTION TARGET TIMELINE ED ED ED ED ED XD INFECTION GOAL TRADITIONAL DETECTION

  10. Slide 10: The VOCAM Plus Advantage

    THE VOCAM PLUS ADVANTAGE One PPB Sensitivity Exclusive Licensing Military Research 1 part per billion sensitivity 1000x more sensitive than other gas chromatography tests GIPL holds the exclusive, worldwide license to implement the VOCAM for use in animal health applications The military currently u

  11. Slide 11: Massive Market Opportunity

    $3B+ 6.8% CAGR o fo) A + Practices MASSIVE MARKET OPPORTUNITY Current $3B+ animal diagnostics market) Animal diagnostics market growth’ Target: 30K+ veterinary practices in us’ 19M annual heartworm tests reported in the US° Full panel of intestinal parasites as well as other animals, including lives

  12. Slide 12: A Scalable Hardware/Software Enabled Solution

    A SCALABLE HARDWARE/SOFTWARE ENABLED SOLUTION HEARTWORM MARKET HW TEST REACH BREAKEVEN AT AVERAGE LOCATION PRACTICE COST = $8 220 DAILY HW TESTS GENERATES $52,000 ANNUALLY $52,000

  13. Slide 13: Proven Traction

    PROVEN TRACTION Y) Y) Y) Y) Y) OVER $1M RAISED EXCLUSIVE 125+ VALIDATING MATURE EARLY PUBLICLY TRADED WORLDWIDE LICENSE SAMPLES HEARTWORMBREATH DETECTION STUDY (OTC: GIPL) SECURED ANALYZED MARKER INITIATED oa ae (fit) 2£@e mu eae a [Vj yy

  14. Slide 14: Team

    Andrew Brown: Founder and CEO ‘Andrew Brown - Andrew began his last venture in 2006 as a pioneer of the restaurant delivery service industry. He founded and led Doorstep Delivery to become a national brand and to a successful exit in 2019. The company sold in a $321M transaction to a public company.

  15. Slide 15: Citations

    Citations . https://pubs.acs.org/doi/10.1021/acsnano.6b04930? . https://www.nature.com/articles/s41598-025-11365-4? . https://www.sciencedirect.com/science/article/abs/pii/S1056872721002397? . https://www.accessdata.fda.gov/cdrh_docs/pdfl0/P100025b.pdf? . https://jamanetwork.com/journals/jamanetwork

Global Innovative Platforms — Investor Presentation (September 2025) on 6ix